FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

391798003: Azapropazone (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
2693688011 Azapropazone en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
2757327016 Azapropazone (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3494630013 Apazone en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
373961000195115 azapropazone it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
1131881000241110 azapropazone fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
402081000274115 Azapropazon de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Azapropazone Is a Non-steroidal anti-inflammatory agent (substance) true Inferred relationship Some
Azapropazone Is a Triazine derivative (substance) true Inferred relationship Some
Azapropazone Is a Uricosuric agent (substance) true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Azapropazone poisoning Causative agent (attribute) True Azapropazone Inferred relationship Some 1
Accidental azapropazone poisoning Causative agent (attribute) False Azapropazone Inferred relationship Some
Intentional azapropazone poisoning Causative agent (attribute) False Azapropazone Inferred relationship Some
Azapropazone poisoning of undetermined intent Causative agent (attribute) False Azapropazone Inferred relationship Some 1
Azapropazone adverse reaction Causative agent (attribute) True Azapropazone Inferred relationship Some 1
Allergy to azapropazone (finding) Causative agent (attribute) False Azapropazone Inferred relationship Some
Azapropazone overdose Causative agent (attribute) True Azapropazone Inferred relationship Some 1
Accidental azapropazone overdose Causative agent (attribute) True Azapropazone Inferred relationship Some 1
Intentional azapropazone overdose Causative agent (attribute) True Azapropazone Inferred relationship Some 1
Azapropazone overdose of undetermined intent Causative agent (attribute) False Azapropazone Inferred relationship Some 1
Product containing azapropazone (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Azapropazone Inferred relationship Some 1
Product containing precisely azapropazone 300 milligram/1 each conventional release oral capsule (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Azapropazone Inferred relationship Some
Azapropazone 600 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Azapropazone Inferred relationship Some
Azapropazone-containing product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Azapropazone Inferred relationship Some 1
Accidental azapropazone poisoning Causative agent (attribute) True Azapropazone Inferred relationship Some 1
Intentional azapropazone poisoning Causative agent (attribute) True Azapropazone Inferred relationship Some 1
Allergy to azapropazone (finding) Causative agent (attribute) True Azapropazone Inferred relationship Some 1
Product containing precisely azapropazone 300 milligram/1 each conventional release oral capsule (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Azapropazone Inferred relationship Some 1
Product containing precisely azapropazone 300 milligram/1 each conventional release oral capsule (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Azapropazone Inferred relationship Some 1
Azapropazone 600 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Azapropazone Inferred relationship Some 1
Azapropazone 600 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Azapropazone Inferred relationship Some 1
Product containing precisely azapropazone 300 milligram/1 each conventional release oral capsule (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Azapropazone Inferred relationship Some 1
Azapropazone 600 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Azapropazone Inferred relationship Some 1
Azapropazone only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Azapropazone Inferred relationship Some 1
Product containing only azapropazone in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Azapropazone Inferred relationship Some 1

This concept is not in any reference sets

Back to Start